KKKyle D. Ketchesin

Kyle D. Ketchesin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kyle D. Ketchesin has a total of 134 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Astrocyte molecular rhythm disruption in nucleus accumbens promotes increased binge-like drinking in mice

    by Tori Keefauver, Nicole L. Horan, Nicole J. Fairbanks, Lillian Morgan, Anisha Saxena, Ryan W. Logan, Gregg E. Homanics, Sean P. Farris, Marianne L. Seney, Kyle D. Ketchesin

    Alcohol misuse is a leading cause of preventable death worldwide. Chronic alcohol is associated with disrupted circadian rhythms, yet molecular mechanisms linking circadian rhythm dysregulation and alcohol consumption are poorly understood. Current FDA-approved treatments for alcohol use disorder (AUD) do not target molecular rhythms or sleep-wake cycles. Mammalian circadian rhythms are regulated by transcription-translation feedback loops that regulate expression of ‘clock genes’ (e.g., Arntl encoding for BMAL1). Both human and rodent studies demonstrate associations between clock gene variants and changes in reward-seeking behavior. Evidence suggests astrocytes, non-neuronal brain cells with cell-autonomous rhythms, may regulate both circadian rhythms and reward. In the nucleus accumbens (NAc), a region responsible for modulating alcohol- and reward-related behavior, over 43% of the astrocyte transcriptome is expressed rhythmically. However, no studies to date have investigated roles of NAc astrocyte rhythmicity in regulating alcohol drinking. We used AAV8-Gfap-Cre to functionally ablate molecular rhythms in NAc astrocytes of BMAL1 floxed mice. Two-bottle choice (2BC), drinking-in-the-light (DIL), and drinking-in-the-dark (DID) assessed alcohol drinking. Behavioral assays included locomotor response to novelty, sucrose preference, and social interaction. Disrupting molecular clock function in NAc astrocytes increased binge-like drinking during both DIL and DID paradigms ( d = 1.44), but not with any other drinking paradigm or behavior. This study carves out a unique role for astrocytes in controlling the temporal organization of reward circuitry and susceptibility to binge-drinking. Future studies will investigate clock-controlled astrocyte mechanisms, such as glutamate uptake and ATP release, that may underlie binge-like drinking behavior.

  • Open Access

    Sex and regional differences in gene expression across the striatum in psychosis

    by Megan S. Perez, RuoFei Yin, Madeline R. Scott, Wei Zong, Marianne L. Seney, Xiangning Xue, Mariah A. Hildebrand, Vaishnavi G. Shankar, Jill R. Glausier, David A. Lewis, et al.

    Psychosis is a hallmark symptom of schizophrenia and highly prevalent in bipolar disorder. Previous work has shown altered gene expression within subregions of the striatum in subjects with psychosis, but it is unclear if these alterations differ across subregions. Moreover, despite known sex differences in the presentation of psychosis (such as age of onset and disease course), it is unclear if there are sex differences in gene expression across subregions of the human striatum in the context of psychosis. Using RNA-sequencing data from human postmortem nucleus accumbens (NAc), caudate, and putamen, we first performed differential expression analyses across these striatal subregions in unaffected (n = 60) and psychosis (n = 36) subjects. For analysis of sex differences, we used equal numbers of males and females in each subject group and evaluated sex and psychosis effects within each brain region. We found that the NAc is the most transcriptionally unique region compared to the caudate and the putamen in both psychosis and unaffected subjects. We also found distinct patterns in gene expression across the three striatal subregions, with an altered pattern of cilia-related genes in subjects with psychosis. Our sex-based analyses showed a striking discordant expression pattern, with opposite effect directions between male and female subjects with psychosis in all three subregions, including a reversal of sex differences in immune- and angiogenesis-related pathways. Overall, we identified regional and sex differences in gene expression across the human striatum that may underlie sex-specific striatal dysfunction and symptomatology in psychosis.


  • Cell-type and sex-specific rhythmic gene expression in the nucleus accumbens

    by Lauren M. DePoy, Kaitlyn A. Petersen, Wei Zong, Kyle D. Ketchesin, Ross C. Matthaei, RuoFei Yin, Megan S. Perez, Chelsea A. Vadnie, Darius Becker-Krail, Madeline R. Scott, et al.

    Circadian rhythms are critical for human health and are highly conserved across species. Disruptions in these rhythms contribute to many diseases, including psychiatric disorders. Previous results suggest that circadian genes modulate behavior through specific cell types in the nucleus accumbens (NAc), particularly dopamine D1-expressing medium spiny neurons (MSNs). However, diurnal rhythms in transcript expression have not been investigated in NAc MSNs. In this study we identified and characterized rhythmic transcripts in D1- and D2-expressing neurons and compared rhythmicity results to homogenate as well as astrocyte samples taken from the NAc of male and female mice. We find that all cell types have transcripts with diurnal rhythms and that top rhythmic transcripts are largely core clock genes, which peak at approximately the same time of day in each cell type and sex. While clock-controlled rhythmic transcripts are enriched for protein regulation pathways across cell type, cell signaling and signal transduction related processes are most commonly enriched in MSNs. In contrast to core clock genes, these clock-controlled rhythmic transcripts tend to reach their peak in expression about 2-h later in females than males, suggesting diurnal rhythms in reward may be delayed in females. We also find sex differences in pathway enrichment for rhythmic transcripts peaking at different times of day. Protein folding and immune responses are enriched in transcripts that peak in the dark phase, while metabolic processes are primarily enriched in transcripts that peak in the light phase. Importantly, we also find that several classic markers used to categorize MSNs are rhythmic in the NAc. This is critical since the use of rhythmic markers could lead to over- or under-enrichment of targeted cell types depending on the time at which they are sampled. This study greatly expands our knowledge of how individual cell types contribute to rhythms in the NAc.


  • Open Access

    Sexually dimorphic mechanisms of VGLUT-mediated protection from dopaminergic neurodegeneration

    by Silas A. Buck, Sophie A. Rubin, Tenzin Kunkhyen, Christoph D. Treiber, Xiangning Xue, Lief E. Fenno, Samuel J. Mabry, Varun R. Sundar, Zilu Yang, Divia Shah, et al.

    Summary: Parkinson’s disease (PD) targets some dopamine (DA) neurons more than others. Sex differences offer insights, with females more protected from DA neurodegeneration. The mammalian vesicular glutamate transporter VGLUT2 and Drosophila ortholog dVGLUT have been implicated as modulators of DA neuron resilience. However, the mechanisms by which VGLUT2/dVGLUT protects DA neurons remain unknown. We discovered DA neuron dVGLUT knockdown increased mitochondrial reactive oxygen species in a sexually dimorphic manner in response to depolarization or paraquat-induced stress, males being especially affected. DA neuron dVGLUT also reduced ATP biosynthetic burden during depolarization. RNA sequencing of VGLUT + DA neurons in mice and flies identified candidate genes that we functionally screened to further dissect VGLUT-mediated DA neuron resilience across PD models. We discovered transcription factors modulating dVGLUT-dependent DA neuroprotection and identified dj-1β as a regulator of sex-specific DA neuron dVGLUT expression. Overall, VGLUT protects DA neurons from PD-associated degeneration by maintaining mitochondrial health.


  • Open Access

    452. The 12 h Transcriptome in Human Prefrontal Cortex and Striatal Subregions and Abnormalities in Schizophrenia

    by Madeline Scott, Kyle Ketchesin, Wei Zong, Mariah Hildebrand, Marianne Seney, Jill Glausier, David Lewis, George Tseng, Colleen McClung

  • Sex Differences in Molecular Rhythms in the Human Cortex

    by Ryan W. Logan, Xiangning Xue, Kyle D. Ketchesin, Gabriel Hoffman, Panos Roussos, George Tseng, Colleen A. McClung, Marianne L. Seney


  • Diurnal rhythms across the human dorsal and ventral striatum

    by Kyle D. Ketchesin, Wei Zong, Mariah A. Hildebrand, Marianne L. Seney, Kelly M. Cahill, Madeline R. Scott, Vaishnavi G. Shankar, Jill R. Glausier, David A. Lewis, George C. Tseng, et al.

    Significance: Circadian rhythms are important in nearly all aspects of brain function. We previously identified diurnal rhythms in transcripts in human cortical regions that are impacted in aging and schizophrenia. Here, we identify diurnal rhythms in transcript expression across the human dorsal and ventral striatum in subjects without psychiatric or neurological disorders. We find some transcripts to be rhythmic across regions and some in only select regions. We also find distinct phase relationships across regions suggesting waves of transcript expression in specific cellular processes across the striatum. These studies establish a temporal map of rhythms across the human striatum and help in understanding the normal function of rhythms in these regions and how disruption could lead to pathology.


  • Valproate reverses mania-like behaviors in mice via preferential targeting of HDAC2

    by Ryan W. Logan, Angela R. Ozburn, Rachel N. Arey, Kyle D. Ketchesin, Alicia Winquist, Andrew Crain, Brian T. D. Tobe, Darius Becker-Krail, Matthew B. Jarpe, Xiangning Xue, et al.

    Valproate (VPA) has been used in the treatment of bipolar disorder since the 1990s. However, the therapeutic targets of VPA have remained elusive. Here we employ a preclinical model to identify the therapeutic targets of VPA. We find compounds that inhibit histone deacetylase proteins (HDACs) are effective in normalizing manic-like behavior, and that class I HDACs (e.g., HDAC1 and HDAC2) are most important in this response. Using an RNAi approach, we find that HDAC2, but not HDAC1, inhibition in the ventral tegmental area (VTA) is sufficient to normalize behavior. Furthermore, HDAC2 overexpression in the VTA prevents the actions of VPA. We used RNA sequencing in both mice and human induced pluripotent stem cells (iPSCs) derived from bipolar patients to further identify important molecular targets. Together, these studies identify HDAC2 and downstream targets for the development of novel therapeutics for bipolar mania.


  • Cell-Type-Specific Regulation of Nucleus Accumbens Synaptic Plasticity and Cocaine Reward Sensitivity by the Circadian Protein, NPAS2

    by Puja K. Parekh, Ryan W. Logan, Kyle D. Ketchesin, Darius Becker-Krail, Micah A. Shelton, Mariah A. Hildebrand, Kelly Barko, Yanhua H. Huang, Colleen A. McClung

    The circadian transcription factor neuronal PAS domain 2 (NPAS2) is linked to psychiatric disorders associated with altered reward sensitivity. The expression of Npas2 is preferentially enriched in the mammalian forebrain, including the nucleus accumbens (NAc), a major neural substrate of motivated and reward behavior. Previously, we demonstrated that downregulation of NPAS2 in the NAc reduces the conditioned behavioral response to cocaine in mice. We also showed that Npas2 is preferentially enriched in dopamine receptor 1 containing medium spiny neurons (D1R-MSNs) of the striatum. To extend these studies, we investigated the impact of NPAS2 disruption on accumbal excitatory synaptic transmission and strength, along with the behavioral sensitivity to cocaine reward in a cell-type-specific manner. Viral-mediated knockdown of Npas2 in the NAc of male and female C57BL/6J mice increased the excitatory drive onto MSNs. Using Drd1a-tdTomato mice in combination with viral knockdown, we determined these synaptic adaptations were specific to D1R-MSNs relative to non-D1R-MSNs. Interestingly, NAc-specific knockdown of Npas2 blocked cocaine-induced enhancement of synaptic strength and glutamatergic transmission specifically onto D1R-MSNs. Last, we designed, validated, and used a novel Cre-inducible short-hairpin RNA virus for MSN-subtype-specific knockdown of Npas2. Cell-type-specific Npas2 knockdown in D1R-MSNs, but not D2R-MSNs, in the NAc reduced cocaine conditioned place preference. Together, our results demonstrate that NPAS2 regulates excitatory synapses of D1R-MSNs in the NAc and cocaine reward-related behavior. SIGNIFICANCE STATEMENT Drug addiction is a widespread public health concern often comorbid with other psychiatric disorders. Disruptions of the circadian clock can predispose or exacerbate substance abuse in vulnerable individuals. We demonstrate a role for the core circadian protein, NPAS2, in mediating glutamatergic neurotransmission at medium spiny neurons (MSNs) in the nucleus accumbens (NAc), a region critical for reward processing. We find that NPAS2 negatively regulates functional excitatory synaptic plasticity in the NAc and is necessary for cocaine-induced plastic changes in MSNs expressing the dopamine 1 receptor (D1R). We further demonstrate disruption of NPAS2 in D1R-MSNs produces augmented cocaine preference. These findings highlight the significance of cell-type-specificity in mechanisms underlying reward regulation by NPAS2 and extend our knowledge of its function.


  • Mood‐related central and peripheral clocks

    by Kyle D. Ketchesin, Darius Becker‐Krail, Colleen A. McClung

    Mood disorders, including major depression, bipolar disorder, and seasonal affective disorder, are debilitating disorders that affect a significant portion of the global population. Individuals suffering from mood disorders often show significant disturbances in circadian rhythms and sleep. Moreover, environmental disruptions to circadian rhythms can precipitate or exacerbate mood symptoms in vulnerable individuals. Circadian clocks exist throughout the central nervous system and periphery, where they regulate a wide variety of physiological processes implicated in mood regulation. These processes include monoaminergic and glutamatergic transmission, hypothalamic–pituitary–adrenal axis function, metabolism, and immune function. While there seems to be a clear link between circadian rhythm disruption and mood regulation, the mechanisms that underlie this association remain unclear. This review will touch on the interactions between the circadian system and each of these processes and discuss their potential role in the development of mood disorders. While clinical studies are presented, much of the review will focus on studies in animal models, which are attempting to elucidate the molecular and cellular mechanisms in which circadian genes regulate mood.